Cash flow Vireo Growth Inc.

Equities

VREO

CA92767B1058

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 03:25:23 2024-09-13 pm EDT			5-day change	1st Jan Change
0.6400 ^CAD	-5.88%		-1.54%	+103.17%

Aug. 20	Vireo Growth Inc. announced that it has received $5.3875 million in funding	CI
Aug. 06	Vireo Growth Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

406fe0e4d2aa6cbfb877c3.Ne8vgPoT09DYMOY94h9JhAycKrwSHMkkqd1IGeDZ1l4.eKt8tI1nprieaohWs0oxzk_5Ydl-XpNnzo0eWKiMv2dltR_ByiWM4r9vtw

Published financial data: VIREO GROWTH INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	29.96M	49.21M	54.45M	74.63M	88.13M
Total Revenues	29.96M	49.21M	54.45M	74.63M	88.13M
Cost of Goods Sold, Total	19.98M	32.08M	34.65M	43.72M	44.03M
Gross Profit	9.98M	17.13M	19.8M	30.91M	44.1M
Selling General & Admin Expenses, Total	24.37M	26.37M	33.66M	33.82M	28.22M
Stock-Based Compensation (IS)	3.3M	12.78M	5.18M	2.69M	4.16M
Depreciation & Amortization - (IS)	1.37M	413K	625K	653K	470K
Amortization of Goodwill and Intangible Assets - (IS)	-	615K	817K	677K	679K
Other Operating Expenses, Total	29.04M	40.17M	40.28M	37.85M	33.52M
Operating Income	-19.07M	-23.04M	-20.48M	-6.94M	10.58M
Interest Expense, Total	-5.18M	-5.1M	-10.58M	-22.59M	-31.26M
Interest And Investment Income	662	-	-	-	-
Net Interest Expenses	-5.18M	-5.1M	-10.58M	-22.59M	-31.26M
Other Non Operating Income (Expenses)	-469K	-6.25M	-245K	1.24M	1.89M
EBT, Excl. Unusual Items	-24.72M	-34.39M	-31.3M	-28.29M	-18.79M
Merger & Related Restructuring Charges	-740K	-	-	-	-
Impairment of Goodwill	-8.54M	-	-	-	-
Gain (Loss) On Sale Of Assets	-23.22K	20.24M	6.9M	322K	-4.48M
Asset Writedown	-19.73M	-	-5.17M	-8.6M	-412K
Other Unusual Items	-3.56M	-	-	-	5.86M
EBT, Incl. Unusual Items	-57.31M	-14.15M	-29.57M	-36.56M	-17.82M
Income Tax Expense	-299K	8.79M	4.12M	5.89M	7.72M
Earnings From Continuing Operations	-57.01M	-22.94M	-33.69M	-42.46M	-25.55M
Net Income to Company	-57.01M	-22.94M	-33.69M	-42.46M	-25.55M
Net Income - (IS)	-57.01M	-22.94M	-33.69M	-42.46M	-25.55M
Net Income to Common Incl Extra Items	-57.01M	-22.94M	-33.69M	-42.46M	-25.55M
Net Income to Common Excl. Extra Items	-57.01M	-22.94M	-33.69M	-42.46M	-25.55M
Per Share Items
Net EPS - Basic	-0.67	-0.24	-0.27	-0.33	-0.19
Basic EPS - Continuing Operations	-0.67	-0.24	-0.27	-0.33	-0.19
Basic Weighted Average Shares Outstanding	85.22M	97.55M	124M	128M	135M
Net EPS - Diluted	-0.67	-0.24	-0.27	-0.33	-0.19
Diluted EPS - Continuing Operations	-0.67	-0.24	-0.27	-0.33	-0.19
Diluted Weighted Average Shares Outstanding	85.22M	97.55M	124M	128M	135M
Normalized Basic EPS	-0.18	-0.22	-0.16	-0.14	-0.09
Normalized Diluted EPS	-0.18	-0.22	-0.16	-0.14	-0.09
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	-16.83M	-22.01M	-19.04M	-5.61M	11.73M
EBITA	-18.2M	-22.43M	-19.66M	-6.26M	11.26M
EBIT	-19.07M	-23.04M	-20.48M	-6.94M	10.58M
EBITDAR	-	-	-16.46M	-3.05M	13.61M
Effective Tax Rate - (Ratio)	0.52	-62.11	-13.94	-16.12	-43.33
Current Domestic Taxes	1.68M	7.43M	5.46M	6.08M	6.04M
Total Current Taxes	1.68M	7.43M	5.46M	6.08M	6.04M
Deferred Domestic Taxes	-1.98M	1.36M	-1.34M	-192K	1.69M
Total Deferred Taxes	-1.98M	1.36M	-1.34M	-192K	1.69M
Normalized Net Income	-15.45M	-21.49M	-19.56M	-17.68M	-11.74M
Interest on Long-Term Debt	5.18M	4.94M	7.89M	15.57M	18.78M
Supplemental Operating Expense Items
Marketing Expenses	-	-	-	-	792K
Selling and Marketing Expenses	-	-	-	-	792K
General and Administrative Expenses	4.04M	-	-	-	-
Net Rental Expense, Total	-	-	2.58M	2.56M	1.88M
Imputed Operating Lease Interest Expense	-	-	3.3M	3.72M	4.27M
Imputed Operating Lease Depreciation	-	-	-718K	-1.16M	-2.39M
Stock-Based Comp., Other (Total)	3.3M	12.78M	5.18M	2.69M	4.16M
Total Stock-Based Compensation	3.3M	12.78M	5.18M	2.69M	4.16M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	7.64M	25.51M	15.16M	15.15M	15.96M
Total Cash And Short Term Investments	7.64M	25.51M	15.16M	15.15M	15.96M
Accounts Receivable, Total	1.03M	487K	1.25M	1.42M	2.26M
Other Receivables	-	210K	42.5K	110K	12.93M
Notes Receivable	-	294K	-	-	3.75M
Total Receivables	1.03M	991K	1.29M	1.53M	18.94M
Inventory	32.44M	12.64M	20.42M	20.51M	19.29M
Prepaid Expenses	2.29M	1.55M	1.56M	2.54M	1.34M
Restricted Cash	1.59M	1.59M	-	-	-
Other Current Assets, Total	6.16M	4.74M	3.21M	7M	93.33M
Total Current Assets	51.15M	47.04M	41.64M	46.73M	149M
Gross Property Plant And Equipment	43.72M	43.62M	116M	106M	34.41M
Accumulated Depreciation	-4.47M	-4.89M	-7.69M	-10.09M	-9.1M
Net Property Plant And Equipment	39.25M	38.73M	108M	95.72M	25.31M
Goodwill	3.13M	3.13M	184K	184K	-
Other Intangibles, Total	9M	8.41M	10.18M	8.78M	8.72M
Loans Receivable Long-Term	-	3.75M	3.75M	3.75M	-
Deferred Tax Assets Long-Term	-	157K	1.5M	1.69M	-
Other Long-Term Assets, Total	2.68M	1.41M	1.72M	2.31M	384K
Total Assets	105M	103M	167M	159M	183M
Liabilities
Accounts Payable, Total	3.03M	901K	1.49M	1.91M	1.77M
Accrued Expenses, Total	106K	5.11M	7.71M	6.17M	27.21M
Current Portion of Long-Term Debt	-	2.01M	-	11.78M	60.22M
Current Portion of Leases	620K	857K	1.6M	1.68M	890K
Current Income Taxes Payable	-	7.23M	5.2M	6.17M	219K
Unearned Revenue Current, Total	-	243K	410K	685K	834K
Other Current Liabilities	-	3.6M	-	1.32M	88.33M
Total Current Liabilities	3.76M	19.94M	16.41M	29.71M	179M
Long-Term Debt	1.93M	-	27.33M	46.25M	9.14M
Long-Term Leases	28.67M	20.34M	80.23M	79.76M	10.54M
Deferred Tax Liability Non Current	4.53M	-	-	-	-
Other Non Current Liabilities	-	-	-	-	156K
Total Liabilities	38.88M	40.28M	124M	156M	199M
Common Stock, Total	118M	-	-	-	-
Additional Paid In Capital	-	164M	178M	181M	187M
Retained Earnings	-60.09M	-102M	-135M	-178M	-203M
Comprehensive Income and Other	7.96M	-	-	-	-
Total Common Equity	66.33M	62.35M	43.01M	3.44M	-16.04M
Total Equity	66.33M	62.35M	43.01M	3.44M	-16.04M
Total Liabilities And Equity	105M	103M	167M	159M	183M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	85.22M	117M	128M	128M	143M
ECS Total Common Shares Outstanding	85.22M	113M	128M	128M	143M
Book Value / Share	0.78	0.55	0.34	0.03	-0.11
Tangible Book Value	54.19M	50.8M	32.64M	-5.52M	-24.76M
Tangible Book Value Per Share	0.64	0.45	0.25	-0.04	-0.17
Total Debt	31.21M	23.21M	109M	139M	80.79M
Net Debt	23.57M	-2.3M	94M	124M	64.83M
Debt Equivalent Oper. Leases	-	-	20.65M	20.45M	15.04M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	22.31K	-	-	-	-
Inventories - Work In Process, Total	24.3M	8.32M	15.17M	14.21M	13.06M
Inventories - Finished Goods, Total	7.79M	4.33M	4.58M	5.51M	5.28M
Inventories - Others	324K	-	674K	792K	949K
Land - (BS)	1.31M	1.31M	1.37M	863K	863K
Buildings, Total	5.52M	7.28M	15.53M	17.57M	15.12M
Machinery, Total	5.48M	5.02M	8.48M	10.36M	8.09M
Full Time Employees	-	376	-	409	385
Part Time Employees	-	101	-	110	105
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	132K	216K	170K	95.69K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-57.01M	-22.94M	-33.69M	-42.46M	-25.55M
Depreciation & Amortization - CF	1.37M	413K	625K	653K	1.3M
Amortization of Goodwill and Intangible Assets - (CF)	864K	615K	817K	677K	679K
Depreciation & Amortization, Total	2.23M	1.03M	1.44M	1.33M	1.98M
Amortization of Deferred Charges, Total - (CF)	52.1K	-	-	-	-
(Gain) Loss From Sale Of Asset	19.33K	-20.21M	-6.47M	-342K	4.48M
(Gain) Loss on Sale of Investments - (CF)	-	-	-437K	-	-
Asset Writedown & Restructuring Costs	28.26M	-	5.17M	8.6M	412K
Stock-Based Compensation (CF)	3.3M	12.78M	5.18M	2.89M	4.16M
Other Operating Activities, Total	6.65M	12.45M	9.33M	16.63M	11.25M
Change In Accounts Receivable	930K	-397K	-3.49M	228K	1.45M
Change In Inventories	-6.01M	-2.66M	-10.35M	-3.99M	-1.82M
Change In Accounts Payable	424K	8.68M	2.65M	30.58K	-1.26M
Change In Income Taxes	-	-	-	-	4.03M
Change in Other Net Operating Assets	-1.32M	337K	134K	-984K	-89.81K
Cash from Operations	-22.46M	-10.93M	-30.52M	-18.07M	-966K
Capital Expenditure	-7.69M	-8.45M	-18.04M	-5.56M	-4.96M
Sale of Property, Plant, and Equipment	1M	-	-	395K	253K
Cash Acquisitions	-14.32M	-	-5.14M	-	-
Divestitures	-	21.14M	15.13M	-	689K
Sale (Purchase) of Intangible assets	-	-	-	237K	-1.09M
Investment in Marketable and Equity Securities, Total	-	-	1.15M	-	-
Other Investing Activities, Total	-1.59M	249K	-306K	-687K	1.64M
Cash from Investing	-22.6M	12.94M	-7.21M	-5.62M	-3.48M
Long-Term Debt Issued, Total	100K	-	27.11M	25.76M	9.15M
Total Debt Issued	100K	-	27.11M	25.76M	9.15M
Long-Term Debt Repaid, Total	-617K	-1.58M	-2.54M	-2.09M	-3.89M
Total Debt Repaid	-617K	-1.58M	-2.54M	-2.09M	-3.89M
Issuance of Common Stock	48.21M	14.01M	1.21M	7.2K	-
Issuance of Preferred Stock	-	-	-	-	-
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-4.62M	3.43M	-	-	-
Cash from Financing	43.08M	15.87M	25.78M	23.68M	5.26M
Net Change in Cash	-1.98M	17.87M	-11.95M	-5.95K	815K
Supplemental Items
Cash Interest Paid	4.62M	5.86M	6.86M	16.56M	24.97M
Cash Income Tax Paid (Refund)	1.4M	370K	5.89M	5.13M	2.04M
Levered Free Cash Flow	-27.82M	-216K	-38.06M	-23.41M	-12.04M
Unlevered Free Cash Flow	-24.63M	2.97M	-31.45M	-9.29M	7.5M
Change In Net Working Capital	10.56M	-12.01M	7.23M	3.65M	-800K
Net Debt Issued / Repaid	-517K	-1.58M	24.57M	23.68M	5.26M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-13.66	-15.32	-9.5	-2.66	3.86
Return on Total Capital	-15.13	-17.16	-10.77	-2.94	6.37
Return On Equity %	-105.59	-41.33	-63.96	-182.82	405.42
Return on Common Equity	-105.59	-41.33	-63.96	-182.82	405.42
Margin Analysis
Gross Profit Margin %	33.3	34.8	36.36	41.42	50.04
SG&A Margin	81.35	53.58	61.81	45.32	32.02
EBITDA Margin %	-56.19	-44.74	-34.97	-7.52	13.31
EBITA Margin %	-60.76	-45.57	-36.12	-8.39	12.77
EBIT Margin %	-63.65	-46.82	-37.62	-9.3	12
Income From Continuing Operations Margin %	-190.31	-46.62	-61.88	-56.89	-28.99
Net Income Margin %	-190.31	-46.62	-61.88	-56.89	-28.99
Net Avail. For Common Margin %	-190.31	-46.62	-61.88	-56.89	-28.99
Normalized Net Income Margin	-51.57	-43.68	-35.93	-23.69	-13.32
Levered Free Cash Flow Margin	-92.87	-0.44	-69.9	-31.37	-13.66
Unlevered Free Cash Flow Margin	-82.23	6.03	-57.76	-12.45	8.51
Asset Turnover
Asset Turnover	0.34	0.52	0.4	0.46	0.51
Fixed Assets Turnover	0.96	1.22	0.74	0.73	1.46
Receivables Turnover (Average Receivables)	50.86	65.06	62.64	55.84	47.93
Inventory Turnover (Average Inventory)	0.74	2.35	2.1	2.14	2.21
Short Term Liquidity
Current Ratio	13.6	2.36	2.54	1.57	0.83
Quick Ratio	2.31	1.31	1	0.56	0.17
Operating Cash Flow to Current Liabilities	-5.97	-0.55	-1.86	-0.61	-0.01
Days Sales Outstanding (Average Receivables)	7.18	5.63	5.83	6.54	7.62
Days Outstanding Inventory (Average Inventory)	491.57	155.81	174.17	170.86	164.95
Average Days Payable Outstanding	32.61	13.8	10.29	14.15	15.66
Cash Conversion Cycle (Average Days)	466.13	147.64	169.72	163.25	156.9
Long Term Solvency
Total Debt/Equity	47.06	37.23	253.82	4.05K	-503.59
Total Debt / Total Capital	32	27.13	71.74	97.59	124.78
LT Debt/Equity	46.12	32.63	250.1	3.66K	-122.69
Long-Term Debt / Total Capital	31.36	23.78	70.69	88.17	30.4
Total Liabilities / Total Assets	36.96	39.25	74.24	97.84	108.75
EBIT / Interest Expense	-3.68	-4.52	-1.94	-0.31	0.34
EBITDA / Interest Expense	-3.25	-4.32	-1.56	-0.14	0.44
(EBITDA - Capex) / Interest Expense	-4.73	-5.98	-3.26	-0.38	0.28
Total Debt / EBITDA	-1.85	-1.05	-6.63	-45.68	5.94
Net Debt / EBITDA	-1.4	0.1	-5.71	-40.72	4.76
Total Debt / (EBITDA - Capex)	-1.27	-0.76	-3.16	-16.19	9.35
Net Debt / (EBITDA - Capex)	-0.96	0.08	-2.72	-14.43	7.5
Growth Over Prior Year